Comparative effectiveness of three benzathine penicillin G-based regimens in people with HIV who presented with early syphilis
6 affiliations
- 1Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan
- 2Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
- 3Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan
- 4Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Medicine, National Taiwan University Cancer Center, Taipei, Taiwan
- 5Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan
- 6Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan; Department of Tropical Medicine and Parasitology, National Taiwan University College of Medicine, Taipei, Taiwan; Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; Corresponding author.
Abstract
Objectives: To compare 12-month serologic responses to three benzathine penicillin G (BPG)-based regimens among people with HIV (PWH) and early syphilis. Methods: We retrospectively included syphilis episodes treated with BPG, BPG plus 7-day doxycycline (BPG/doxycycline), or BPG/doxycycline plus single-dose ceftriaxone during 2018-2024. Episodes with baseline rapid plasma reagin (RPR) titers <1:4 or exposure to other Treponema pallidum -active antibiotics were excluded. Serologic response was defined as a ≥ 4-fold RPR decline at 12 months. Intention-to-treat (ITT) with last-observation-carried-forward and per-protocol analyses were performed. Results: Among 1077 episodes in 762 PWH, 453 received BPG, 570 BPG/doxycycline, and 54 BPG/doxycycline/ceftriaxone. ITT response rates were 74.6%, 83.2%, and 88.9%, respectively ( P < 0.001); per-protocol rates were 74.4%, 83.4%, and 89.8% ( P < 0.001). Higher baseline RPR titers and doxycycline-containing regimens were independently associated with response. In analyses directly comparing BPG/doxycycline with and without ceftriaxone, adding ceftriaxone to BPG/doxycycline was not significantly associated with a higher serologic response. Conclusions: BPG/doxycycline was associated with a higher likelihood of 12-month serologic response. The incremental association of ceftriaxone remained uncertain because of the small number of ceftriaxone-treated episodes.
Related
- COMPARATIVE EFFECTIVENESS OF TECLISTAMAB VS REAL-WORLD PHYSICIAN’S CHOICE OF CARFILZOMIB-AND/OR POMALIDOMIDE-BASED REGIMENS IN LOCOMMOTION AND MOMMENT IN TCE RRMM
- Comparative Efficacy of Vancomycin and Fidaxomicin Regimens for the Prevention of Recurrent Clostridioides difficile Infection: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
- Economic burden and quality of life of IgG4-related disease in China: A comparative analysis of three treatment regimens.
- Claims-Based Body Mass Index and Obesity Comparative Effectiveness Research—Weighing the Evidence
- Comparative Effectiveness of Hysteroscopic Endometrial Resection Versus the 52-mg Levonorgestrel-Releasing Intrauterine System for Heavy Menstrual Bleeding: A Retrospective Cohort Study
BibTeX
@article{chen2026comparative,
title = {{Comparative effectiveness of three benzathine penicillin G-based regimens in people with HIV who presented with early syphilis}},
author = {Kai-Hsiang Chen and Hsin-Yun Sun and Kuan-Yin Lin and Yu-Shan Huang and Sung-Hsi Huang and Wang-Da Liu and Yi-Chia Huang and Tzong-Yow Wu and Yu-Chung Chuang and Aristine Cheng and Li-Hsin Su and Chien-Ching Hung},
journal = {International Journal of Infectious Diseases},
year = {2026},
month = oct,
doi = {10.1016/j.ijid.2026.109069},
url = {https://doi.org/10.1016/j.ijid.2026.109069},
note = {CC BY},
}
RIS
TY - JOUR
TI - Comparative effectiveness of three benzathine penicillin G-based regimens in people with HIV who presented with early syphilis
AU - Kai-Hsiang Chen
AU - Hsin-Yun Sun
AU - Kuan-Yin Lin
AU - Yu-Shan Huang
AU - Sung-Hsi Huang
AU - Wang-Da Liu
AU - Yi-Chia Huang
AU - Tzong-Yow Wu
AU - Yu-Chung Chuang
AU - Aristine Cheng
AU - Li-Hsin Su
AU - Chien-Ching Hung
PY - 2026
DA - 2026/10/30
JO - International Journal of Infectious Diseases
DO - 10.1016/j.ijid.2026.109069
UR - https://doi.org/10.1016/j.ijid.2026.109069
AB - Objectives: To compare 12-month serologic responses to three benzathine penicillin G (BPG)-based regimens among people with HIV (PWH) and early syphilis. Methods: We retrospectively included syphilis episodes treated with BPG, BPG plus 7-day doxycycline (BPG/doxycycline), or BPG/doxycycline plus single-dose ceftriaxone during 2018-2024. Episodes with baseline rapid plasma reagin (RPR) titers <1:4 or exposure to other Treponema pallidum -active antibiotics were excluded. Serologic response was defined as a ≥ 4-fold RPR decline at 12 months. Intention-to-treat (ITT) with last-observation-carried-forward and per-protocol analyses were performed. Results: Among 1077 episodes in 762 PWH, 453 received BPG, 570 BPG/doxycycline, and 54 BPG/doxycycline/ceftriaxone. ITT response rates were 74.6%, 83.2%, and 88.9%, respectively ( P < 0.001); per-protocol rates were 74.4%, 83.4%, and 89.8% ( P < 0.001). Higher baseline RPR titers and doxycycline-containing regimens were independently associated with response. In analyses directly comparing BPG/doxycycline with and without ceftriaxone, adding ceftriaxone to BPG/doxycycline was not significantly associated with a higher serologic response. Conclusions: BPG/doxycycline was associated with a higher likelihood of 12-month serologic response. The incremental association of ceftriaxone remained uncertain because of the small number of ceftriaxone-treated episodes.
SN - 1201-9712
SN - 1878-3511
ER -